Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.

ABSTRACT:

SUBMITTER: Miltiades P 

PROVIDER: S-EPMC3944665 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature